Early Erythropoietin Administration does not Increase the Risk of Retinopathy in Preterm Infants

Pediatrics and Neonatology

Volumn 58, Issue 1, 2017, Pages 48-56

  Chou, Hsin Hsu ^a,b   Chung, Mei Yung ^c   Zhou, Xiao Guang ^d   Lin, Hung Chih ^e  

^a Departments of Medical Research Ditmanson Medical Foundation Chia Yi Christian Hospital   (Taiwan)

^b CHIA NAN UNIVERSITY OF PHARMACY AND SCIENCE   (Taiwan)

^c CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^d CHILDREN S HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

^e CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

erythropoietin; meta analysis; retinopathy of prematurity

Indexed keywords

ERYTHROPOIETIN; ANTIANEMIC AGENT;

ARTICLE; ARTIFICIAL VENTILATION; BIRTH WEIGHT; DRUG EFFICACY; DRUG SAFETY; EARLY INTERVENTION; ERYTHROCYTE TRANSFUSION; GESTATIONAL AGE; HUMAN; INFANT; LOW BIRTH WEIGHT; OXYGEN THERAPY; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROLENTAL FIBROPLASIA; SYSTEMATIC REVIEW; META ANALYSIS; NEWBORN; RETINOPATHY OF PREMATURITY; RISK;

ERYTHROPOIETIN; HEMATINICS; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; RETINOPATHY OF PREMATURITY; RISK;

EID: 85006699149     PISSN: 18759572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pedneo.2016.03.006     Document Type: Article

References (40)

1. 1 Arif, B., Ferhan, K., Recombinant human erythropoietin therapy in low-birthweight preterm infants: a prospective controlled study. Pediatr Int 47 (2005), 67–71.
2. 2 Maier, R.F., Obladen, M., Scigalla, P., Linderkamp, O., Duc, G., Hieronimi, G., et al. The effect of epoetin beta (recombinant human erythropoietin) on the need for transfusion in very-low-birth-weight infants. European Multicentre Erythropoietin Study Group. N Engl J Med 330 (1994), 1173–1178.
3. 3 Ohls, R.K., Ehrenkranz, R.A., Wright, L.L., Lemons, J.A., Korones, S.B., Stoll, B.J., et al. Effects of early erythropoietin therapy on the transfusion requirements of preterm infants below 1250 grams birth weight: a multicenter, randomized, controlled trial. Pediatrics 108 (2001), 934–942.
4. 4 Ohlsson, A., Aher, S.M., Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev(4), 2014, CD004863.
5. 5 Kandasamy, Y., Kumar, P., Hartley, L., The effect of erythropoietin on the severity of retinopathy of prematurity. Eye (Lond) 28 (2014), 814–818.
6. 6 Suk, K.K., Dunbar, J.A., Liu, A., Daher, N.S., Leng, C.K., Leng, J.K., et al. Human recombinant erythropoietin and the incidence of retinopathy of prematurity: a multiple regression model. J AAPOS 12 (2008), 233–238.
7. 7 Fleck, B.W., Management of retinopathy of prematurity. Arch Dis Child Fetal Neonatal Ed 98 (2013), F454–F456.
8. 8 Urao, N., Okigaki, M., Yamada, H., Aadachi, Y., Matsuno, K., Matsui, A., et al. Erythropoietin-mobilized endothelial progenitors enhance reendothelialization via Akt-endothelial nitric oxide synthase activation and prevent neointimal hyperplasia. Circ Res 98 (2006), 1405–1413.
9. 9 Mowat, F.M., Gonzalez, F., Luhmann, U.F., Lange, C.A., Duran, Y., Smith, A.J., et al. Endogenous erythropoietin protects neuroretinal function in ischemic retinopathy. Am J Pathol 180 (2012), 1726–1739.
10. 10 Chen, J., Connor, K.M., Aderman, C.M., Smith, L.E., Erythropoietin deficiency decreases vascular stability in mice. J Clin Invest 118 (2008), 526–533.
11. 11 Loeliger, M.M., Mackintosh, A., De Matteo, R., Harding, R., Rees, S.M., Erythropoietin protects the developing retina in an ovine model of endotoxin-induced retinal injury. Invest Ophthalmol Vis Sci 52 (2011), 2656–2661.
12. 12 Figueras-Aloy, J., Alvarez-Domínguez, E., Morales-Ballus, M., Salvia-Roiges, M.D., Moretones-Suñol, G., Early administration of erythropoietin in the extreme premature, a risk factor for retinopathy of prematurity?. An Pediatr (Barc) 73 (2010), 327–333 [Article in Spanish].
13. 13 Chong, Z.Z., Kang, J.Q., Maiese, K., Erythropoietin fosters both intrinsic and extrinsic neuronal protection through modulation of microglia, Akt1, Bad, and caspase-mediated pathways. Br J Pharmacol 138 (2003), 1107–1118.
14. 14 Demers, E.J., McPherson, R.J., Juul, S.E., Erythropoietin protects dopaminergic neurons and improves neurobehavioral outcomes in juvenile rats after neonatal hypoxia-ischemia. Pediatr Res 58 (2005), 297–301.
15. 15 McAdams, R.M., McPherson, R.J., Mayock, D.E., Juul, S.E., Outcomes of extremely low birth weight infants given early high-dose erythropoietin. J Perinatol 33 (2013), 226–230.
16. 16 Leuchter, R.H., Gui, L., Poncet, A., Hagmann, C., Lodygensky, G.A., Martin, E., et al. Association between early administration of high-dose erythropoietin in preterm infants and brain MRI abnormality at term-equivalent age. JAMA 312 (2014), 817–824.
17. 17 Higgins, J.P.T., Green, S., Cochrane Handbook for Systematic Reviews of Interventions. 2008, The Cochrane Collaboration, Oxford, UK.
18. 18 Maier, R.F., Obladen, M., Müller-Hansen, I., Kattner, E., Merz, U., Arlettaz, R., et al. Early treatment with erythropoietin beta ameliorates anemia and reduces transfusion requirements in infants with birth weights below 1000 g. J Pediatr 141 (2002), 8–15.
19. 19 Carnielli, V.P., Da Riol, R., Montini, G., Iron supplementation enhances response to high doses of recombinant human erythropoietin in preterm infants. Arch Dis Child Fetal Neonatal Ed 79 (1998), F44–F48.
20. 20 Fauchère, J.C., Dame, C., Vonthein, R., Koller, B., Arri, S., Wolf, M., et al. An approach to using recombinant erythropoietin for neuroprotection in very preterm infants. Pediatrics 122 (2008), 375–382.
21. 21 Haiden, N., Cardona, F., Schwindt, J., Berger, A., Kuhle, S., Homoncik, M., et al. Changes in thrombopoiesis and platelet reactivity in extremely low birth weight infants undergoing erythropoietin therapy for treatment of anaemia of prematurity. Thromb Haemost 93 (2005), 118–123.
22. 22 Pollak, A., Hayde, M., Hayn, M., Herkner, A., Lombard, K.A., Lubec, G., et al. Effect of intravenous iron supplementation on erythropoiesis in erythropoietin-treated premature infants. Pediatrics 107 (2001), 78–85.
23. 23 Yeo, C.L., Choo, S., Ho, L.Y., Effect of recombinant human erythropoietin on transfusion needs in preterm infants. J Paediatr Child Health 37 (2001), 352–358.
24. 24 Ohls, R.K., Christensen, R.D., Kamath-Rayne, B.D., Rosenberg, A., Wiedmeier, S.E., Roohi, M., et al. A randomized, masked, placebo-controlled study of darbepoetin alfa in preterm infants. Pediatrics 132 (2013), e119–e127.
25. 25 Al-Kharfy, T., Smyth, J.A., Wadsworth, L., Krystal, G., Fitzgerald, C., Davis, J., et al. Erythropoietin therapy in neonates at risk of having bronchopulmonary dysplasia and requiring multiple transfusions. J Pediatr 129 (1996), 89–96.
26. 26 Shannon, K.M., Keith, J.F. 3rd, Mentzer, W.C., Ehrenkranz, R.A., Brown, M.S., Widness, J.A., et al. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants. Pediatrics 95 (1995), 1–8.
27. 27 Xu, X.J., Huang, H.Y., Chen, H.L., Erythropoietin and retinopathy of prematurity: a meta-analysis. Eur J Pediatr 173 (2014), 1355–1364.
28. 28 Ohlsson, A., Aher, S.M., Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev(9), 2012, CD004863.
29. 29 Aher, S.M., Ohlsson, A., Late erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants. Cochrane Database Syst Rev(9), 2012, CD004868.
30. 30 Romagnoli, C., Zecca, E., Gallini, F., Girlando, P., Zuppa, A.A., Do recombinant human erythropoietin and iron supplementation increase the risk of retinopathy of prematurity?. Eur J Pediatr 159 (2000), 627–628.
31. 31 Loh, A., Hadziahmetovic, M., Dunaief, J.L., Iron homeostasis and eye disease. Biochim Biophys Acta 1790 (2009), 637–649.
32. 32 Inder, T.E., Clemett, R.S., Austin, N.C., Graham, P., Darlow, B.A., High iron status in very low birth weight infants is associated with an increased risk of retinopathy of prematurity. J Pediatr 131 (1997), 541–544.
33. 33 Dani, C., Reali, M.F., Bertini, G., Martelli, E., Pezzati, M., Rubaltelli, F.F., The role of blood transfusions and iron intake on retinopathy of prematurity. Early Hum Dev 62 (2001), 57–63.
34. 34 Hirano, K., Morinobu, T., Kim, H, Hiroi, M, Ban, R, Ogawa, S, et al. Blood transfusion increases radical promoting non-transferrin bound iron in preterm infants. Arch Dis Child Fetal Neonatal Ed 84 (2001), F188–F193.
35. 35 Jelkmann, W., Wagner, K., Beneficial and ominous aspects of the pleiotropic action of erythropoietin. Ann Hematol 83 (2004), 673–686.
36. 36 Sato, T., Kusaka, S., Shimojo, H., Fujikado, T., Vitreous levels of erythropoietin and vascular endothelial growth factor in eyes with retinopathy of prematurity. Ophthalmology 116 (2009), 1599–1603.
37. 37 Chen, J., Smith, L.E., A double-edged sword: erythropoietin eyed in retinopathy of prematurity. J AAPOS 12 (2008), 221–222.
38. 38 Sears, J.E., Stimulating angiogenesis to prevent ischemic retinopathy. Ophthalmology 116 (2009), 1597–1598.
39. 39 Chawla, D, Agarwal, R, Deorari, AK, Paul, VK, Retinopathy of prematurity. Indian J Pediatr 75 (2008), 73–76.
40. 40 Hakeem, A.H., Mohamed, G.B., Othman, M.F., Retinopathy of prematurity: a study of prevalence and risk factors. Middle East Afr J Ophthalmol 19 (2012), 289–294.